HIV/AIDS
Conditions
Interventions
Brief intervention
Sponsors
University of California San Francisco
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Clinical Component (Randomized Control trial): - age =18 years - HIV-seropositive - on or initiating ART - not planning to move or travel within 12 weeks following entry in the study - Tobacco inclusion criteria: current tobacco users, i.e. used tobacco in the past 7 days; for smokers, smoked at least 100 cigarettes in lifetime, and at least 5 cigarettes per day, verified by expired Carbon Monoxide (CO)= 5-6 parts per million (ppm). - access to mobile phone for phone contact (and on intensive intervention also for text follow up visit) Additional inclusion criteria for intensive intervention only: - able to read or be read for the SMS messages
Exclusion criteria
Exclusion criteria: Clinical Component: - age < 18 years - HIV-seronegative - unable to provide informed consent - unwilling to be contacted by clinic for follow up - Opioid users (who may be receiving Bupropion as part of their treatment) Additional exclusion criteria for intensive intervention only: - Myocardial Infarction in the 2 weeks prior to enrolling in the study - Pregnant (as NRT and Bupropion might be contraindicated). - We will also exclude patients for whom Bupropion is contraindicated (e.g. history of seizures, recent use of MAO inhibitors, breastfeeding, and whose ART protocol present, as per prescription guidance, contraindications). - For those who share phones, prior disclosure of HIV status to the phone owner will be required to prevent inadvertent disclosure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective is to compare the efficacy of a brief versus an intensive intervention in supporting PLHIV in quitting tobacco use. The time frame is 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objectives are to compare cessation status by brief versus intensive intervention at 1, 3 and 6 months. Other secondary objectives include: - Changes in providers self-reported tobacco dependence treatment interventions overtime and between groups - Assess cost-effectiveness of the brief versus intensive interventions | — |
Countries
Kenya
Contacts
Public ContactCirilus Ogolla
Study coordinator
Outcome results
None listed